Pfizer has asked the FDA for an emergency authorisation of the vaccine in the US and the US government expects to the first tranche to include about 6.4 million doses. In a separate announcement ...

Pfizer said it will cut another $1.7 billion (€1.5 ... with its emphasis on automation will mean further job losses in Ireland. The announcement came alongside publication of the drugmaker ...

Pfizer is laying off around 100 manufacturing staff at its plant in Newbridge, Co Kildare, as part of a global round of job cuts aimed ...

Pfizer has said it will shed staff and cut its operating costs by around $ ... It has not provided any indication of the number of job losses. Around $4.2 billion of the correction will result ...

That wasn’t enough to encourage investors. Pfizer’s shares were largely unchanged in early trading. The new cuts on Tuesday come as the drugmaker struggles to find sources of growth amid declining ...

U.S.-based employers announced 105,441 job cuts in April, down 62% from March but up 63% from those announced in March 2024, according to the Challenger report released on Thursday. The tally is ...

Pfizer has a separate multiyear initiative to slash costs, with the first phase of the effort slated to deliver $1.5 billion in savings by the end of 2027. With the added cuts announced Tuesday ...

With the added cuts announced Tuesday, Pfizer now expects to deliver around $7.7 billion in savings by the end of 2027 from the two cost-cutting efforts. Pfizer maintained its 2025 guidance but ...

Pfizer on Tuesday expanded its cost-cutting efforts and reported first-quarter profit that topped estimates, even as the company's sales fell, largely due to dwindling revenue for its antiviral ...

Pfizer Inc. (NYSE:PFE – Get Free Report)’s stock price rose 1.5% during mid-day trading on Thursday following a dividend announcement ... Finally, UBS Group cut their price objective on ...

(Reuters) -Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research operations, highlighting its operational efficiency even as it ...

Results showed that adding sasanlimab to BCG cut the risk of disease-related events by 32% in the overall study population. This effect was stronger in patients with early-stage or CIS disease, who ...